Stauber granted distribution rights for Bimuno

April 10, 2020

Clasado Biosciences granted Stauber non-exclusive rights to distribute its Bimuno prebiotic ingredient.

Clasado Biosciences (Reading, UK), an international biotechnology company that develops prebiotics and gut-health solutions, granted Stauber (Fullerton, CA) non-exclusive rights to distribute its Bimuno prebiotic ingredient. Bimuno uses a proprietary galactooligosaccharides (GOS) mixture to feed and stimulate the growth of bifidobacterial.

“We share the belief that science-backed digestive health should be effective and accessible to everyone,” said Per Rehné, CEO at Clasado Biosciences, in a press release. “Consumers are seeking new ways to bolster and support the wider functions of the body, and Bimuno is a demonstrable way to do this. The North American market is one of the fastest growing geographies for prebiotic supplements, and we’re excited about the opportunity that lies ahead for Clasado to grow in this region.”